A phase Ib study of sorafenib (BAY 43-9006) in patients with Kaposi sarcoma

Thomas S. Uldrick^*, Priscila H. Gonçalves, Kathleen M. Wyvill, Cody J. Peer, Wendy Bernstein, Karen Aleman, Mark N. Polizzotto, David Venzon, Seth M. Steinberg, Vickie Marshall, Denise Whitby, Richard F. Little, John J. Wright, Michelle A. Rudek, William D. Figg, Robert Yarchoan

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review